Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZAGER, R. A.
Right arrow Articles by JOHNSON, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZAGER, R. A.
Right arrow Articles by JOHNSON, A.
J Am Soc Nephrol 11:894-902, 2000
© 2000 American Society of Nephrology

REGULAR ARTICLES

Sphingomyelinase and Membrane Sphingomyelin Content

Determinants ofProximal Tubule Cell Susceptibility to Injury

RICHARD A. ZAGER, KRISTIN M. BURKHART and ALI JOHNSON

The Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington.

Correspondence to Dr. Richard A. Zager, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Room D2-190, Seattle, WA 98109. Phone: 206-667-6549; Fax: 206-667-5424; E-mail: dzager{at}fhcrc.org

Abstract. Ceramides acutely accumulate in proximal tubules during injury. Pathogenic relevance of this change is suggested by observations that adding ceramide to tubular cells alters superimposed hypoxic and toxic attack. Ceramide accumulation during cell injury is thought to arise from sphingomyelinase (SMase)-mediated sphingomyelin (SM) hydrolysis ± decreased catabolism. Thus, ceramide addition to cells cannot precisely simulate pathophysiologic events. Therefore, this study assessed direct effects of SMase activity on tubular cell viability under basal conditions and during superimposed attack. Cultured human proximal tubule (HK-2) cells were exposed to differing SMase doses. Its effects on cell phospholipids, ceramides, proliferation rates, and susceptibility to injury (ATP depletion, Fe-mediated oxidant stress) were assessed. Because SMase reduces cell SM content, the effect of exogenous SM on membrane injury (intact cells, isolated vesicles) was also tested. Finally, because SM decreases membrane fluidity, the impact of a fluidizing agent (A2C) on membrane injury (phospholipase A2, lipid peroxidation) was addressed. SMase reduced HK-2 SM content by approximately 33%, but only modest ceramide increments resulted (suggesting high endogenous ceramidase activity). SMase, by itself, caused no cell death (lactate dehydrogenase release). However, it was mildly antiproliferative, and it dramatically predisposed to both ATP depletion- and Fe-mediated attack. SMase also predisposed isolated vesicles to damage, suggesting that its impact on intact cells reflects a direct membrane effect. Adding SM to intact cells (or vesicles) mitigated ATP depletion and Fe- and phospholipase A2-induced damage. In contrast, A2C rendered membranes more vulnerable to attack. SMase predisposes tubular cells to superimposed ATP depletion and oxidant injury. This may be explained by SM losses, and not simply cytotoxic ceramide gains, given that SM can directly decrease cell/membrane damage. The ability of SM to decrease membrane fluidity may explain, at least in part, its cytoprotective effect.




This article has been cited by other articles:


Home page
 Mol Biol EvolHome page
Q. Xu, C.-H. C. Cheng, P. Hu, H. Ye, Z. Chen, L. Cao, L. Chen, Y. Shen, and L. Chen
Adaptive Evolution of Hepcidin Genes in Antarctic Notothenioid Fishes
Mol. Biol. Evol., June 1, 2008; 25(6): 1099 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. M. P. Cabral, M. Wengert, A. A. A. da Ressurreicao, P. H. P. Feres-Elias, F. G. Almeida, A. Vieyra, C. Caruso-Neves, and M. Einicker-Lamas
Ceramide Is a Potent Activator of Plasma Membrane Ca2+-ATPase from Kidney Proximal Tubule Cells with Protein Kinase A as an Intermediate
J. Biol. Chem., August 24, 2007; 282(34): 24599 - 24606.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Grimm, R. Kraft, G. Schultz, and C. Harteneck
Activation of the Melastatin-Related Cation Channel TRPM3 by D-erythro-Sphingosine
Mol. Pharmacol., March 1, 2005; 67(3): 798 - 805.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. K. Van Why, A. S. Mann, T. Ardito, G. Thulin, S. Ferris, M. A. Macleod, M. Kashgarian, and N. J. Siegel
Hsp27 Associates with Actin and Limits Injury in Energy Depleted Renal Epithelia
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 98 - 106.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. Gueler, S. Rong, J.-K. Park, A. Fiebeler, J. Menne, M. Elger, D. N. Mueller, F. Hampich, R. Dechend, U. Kunter, et al.
Postischemic Acute Renal Failure Is Reduced by Short-Term Statin Treatment in a Rat Model
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2288 - 2298.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. A. Zager and T. F. Kalhorn
Changes in Free and Esterified Cholesterol : Hallmarks of Acute Renal Tubular Injury and Acquired Cytoresistance
Am. J. Pathol., September 1, 2000; 157(3): 1007 - 1016.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673